Clinical Trial Update: Dendritic Cell-based Immunotherapy in Mesothelioma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating dendritic cell-based immunotherapy for malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Snippet

Sponsor: Erasmus Medical Center | Conditions: Malignant Pleural Mesothelioma | Phase 1 | Status: COMPLETED